Baymatob Operations Pty Ltd: Clinical Trials

1 active not recruiting. 1 Not applicable.

By phase and status

Phase	Trials	Status
Not applicable	1	Active not recruiting 1

Follow Baymatob Operations Pty Ltd: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Pivotal, Prospective, Multi-centre, Single-arm Study to Evaluate the Safety and Effectiveness of Oli for Identification of Patients, During the Intrapartum Period, Who Are at Higher Risk of Developing Abnormal Postpartum Uterine Bleeding, Including Postpartum Haemorrhage Oli is a non-invasive, wearable device, designed to provide clinicians with an early indication if the participant is at a higher risk of developing abnormal postpartum uterine bleeding - Post Partum Haemorrhage, Maternal Care Patterns	Not applicable	Active not recruiting	Baymatob Operations Pty Ltd	1000	2025-08-06	2026-07-01

Conditions studied

Postpartum Hemorrhage (1)

Interventions

Wearable Electronic Devices (1)

Countries

Australia (1)  ·  United States (1)